How likely are COVID-19 interventions to benefit the sickest patients?

Intensive Care Med. 2020 Jul;46(7):1441-1444. doi: 10.1007/s00134-020-06131-1. Epub 2020 Jun 9.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Antiviral Agents / therapeutic use*
  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / therapy
  • Critical Illness / therapy
  • Humans
  • Immunization, Passive
  • Immunotherapy
  • Interferons / therapeutic use
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / therapy
  • SARS-CoV-2

Substances

  • Adrenal Cortex Hormones
  • Antiviral Agents
  • Interferons

Supplementary concepts

  • COVID-19 serotherapy